amsacrine has been researched along with Bone Marrow Diseases in 2 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Bone Marrow Diseases: Diseases involving the BONE MARROW.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Case, DC | 1 |
Fyfe, D | 1 |
Price, C | 1 |
Langley, RE | 1 |
Pagonis, C | 1 |
Houghton, J | 1 |
Osborne, L | 1 |
Woll, PJ | 1 |
Gardner, C | 1 |
Baguley, BC | 1 |
Carmichael, J | 1 |
1 trial available for amsacrine and Bone Marrow Diseases
Article | Year |
---|---|
A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day schedule.
Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Area Under Curve; Bone Marrow Diseases; Dose-Response | 2001 |
1 other study available for amsacrine and Bone Marrow Diseases
Article | Year |
---|---|
m-AMSA: phase II trial in advanced lymphoma and leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Agents; Bone Marro | 1984 |